Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Palmitic acid monoethanolamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clearmind Medicine Publishes Six Innovative Patents In Hong Kong
    Clearmind Medicine Publishes Six Innovative Patents In Hong Kong

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257304/0/en/Clearmind-Medicine-Announces-Publication-of-Six-Innovative-Patents-in-Hong-Kong-for-Next-Generation-Psychedelic-Based-Combination-Therapies.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Scisparc, Clearmind Medicine Partner For Depression Therapy
    Scisparc, Clearmind Medicine Partner For Depression Therapy

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256253/0/en/SciSparc-NeuroThera-Labs-Clearmind-Medicine-Collaboration-Leads-to-Patent-Application-for-Depression-Therapy.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Clearmind Medicine Files Hong Kong Patent For Depression Therapy
    Clearmind Medicine Files Hong Kong Patent For Depression Therapy

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255403/0/en/Clearmind-Medicine-Announces-Hong-Kong-Patent-Filing-for-Depression-Therapy.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    Clearmind Gets Patent for Weight Loss and Fatty Liver Therapy
    Clearmind Gets Patent for Weight Loss and Fatty Liver Therapy

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252856/0/en/Clearmind-Medicine-Announces-Publication-of-International-Patent-for-Novel-Therapy-Targeting-Weight-Loss-and-Fatty-Liver-Disease.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Neurothera, Clearmind Secure Patent for Novel Depression Therapy
    Neurothera, Clearmind Secure Patent for Novel Depression Therapy

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191728/0/en/SciSparc-Neurothera-Labs-Announces-Israeli-Patent-Application-in-Collaboration-with-Clearmind-Medicine-for-Novel-Non-Hallucinogenic-Neuroplastogen-Treatment-for-Depression.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Clearmind Files Patent for Non-Hallucinogenic Psychedelic Drug
    Clearmind Files Patent for Non-Hallucinogenic Psychedelic Drug

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189045/0/en/Clearmind-Medicine-Files-Israeli-Patent-for-Novel-Non-Hallucinogenic-Neuroplastogen-Treatment-for-Depression.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.